Student Life at BC Cancer Research

GrasPods- organizing social activities for trainees at BC Cancer

BC Cancer has a diverse, productive, and vibrant student and postdoctoral fellow community comprised of trainees affiliated with various academic departments at the University of British Columbia, Simon Fraser University, and the University of Victoria.

With 580 trainees in 2017/18, students are at the heart of innovation at BC Cancer.

Search current student and traineeship opportunities.

GrasPods

GrasPods- part of the vibrant trainee community at BC Cancer

The BCCRC Graduate Student and Post Doctoral Society (GrasPods) is a trainee-run society whose mission is to further enrich the wonderful training environment at BC Cancer by providing academic, social, and personal well-being support for their members. 

GrasPods events include:

  • Academic Workshops
  • Sports
  • Trainee Lunches
  • Jobs in Science Interview Series

Learn More

Featured Recruiter

Dr. Tim Lee, PhD

Senior Scientist
Cancer Control Research

Tim Lee is a Senior Scientist who works specifically on early skin cancer detection and epidemiologic research on skin cancer. Tim’s research interests include medical image analysis, artificial intelligence, polarization speckle, computer-aided diagnosis, and risk and prognosis factors of skin cancer.

Research Interests:

  • Polarization speckle: in vivo skin cancer screening technique
  • Artificial intelligence and computer aided diagnostic algorithms for analyzing skin images
  • Risk and prognosis factors for melanoma

Dr. Samuel Aparicio, BM BCh PhD FRCPath FRSC

Distinguished Scientist, Department Head
Molecular Oncology

Dr. Samuel Aparicio (BM, BCh, PhD, FRCPath, FRSC) is the Nan & Lorraine Robertson Chair in Breast Cancer Research, holds the Canada Research Chair (Tier 1) in Molecular Oncology, and is the recipient of the 2014 Aubrey J Tingle Prize. He is also Head of the Department of Breast and Molecular Oncology at BC Cancer Research, part of the Provincial Health Services Authority, and a Professor in the Department of Pathology and Laboratory Medicine at UBC.  

Learn More

Dr. Marco Marra, OBC, PhD, FRS(C), FCAHS

Director and Distinguished Scientist, Canada's Michael Smith Genome Sciences Centre, BC Cancer
Genome Sciences Centre

Dr. Marco Marra has been instrumental in bringing genome science to Canada, working across diverse programs of research that have addressed pressing problems and key opportunities of relevance to Canada and Canadians. He has spent much of his career leading teams to conduct large-scale, high-throughput genomics projects with the aim of comprehensive identification of the gentic changes that drive cancer. He believes that better integration of informatics and biology in genome analysis and a strong interface between the lab and the clinic can change outcomes for cancer patients. 

Learn More

Dr. Steven Jones, PhD, FRS(C), FCAHS

Head of Bioinformatics and Co-Director, Michael Smith Genome Sciences Centre, BC Cancer
Genome Sciences Centre

Dr. Jones’ research program is firmly entrenched in genome science to better understand the complete mutational landscape of cancers. His primary aim is to help uncover the diversity of genetic and genomic events that accrue to give rise to cancers, and which also encourage their evolution and maintain their progression. His laboratory extensively analyzes Next Generation genome and transcriptome data to achieve these goals. Dr.

Learn More

Dr. Rob Holt, PhD

Distinguished Scientist, Canada’s Michael Smith Genome Sciences Centre, BC Cancer
Genome Sciences Centre

After completing his PhD in Pharmacology at the University of Alberta in 1998, Dr. Robert Holt conducted his post-doctoral research at the State University of New York in Albany, NY. He joined the faculty at the University of British Columbia in 2003 where he is now a Professor in the Department of Medical Genetics, a Faculty Member of the Genome Science and Technology program, the Interdisciplinary Oncology Graduate Program, the Genetics Graduate Program and the Health Brain Research Centre.

Learn More

Dr. Angela Brooks-Wilson, PhD

Distinguished Scientist, Canada's Michael Smith Genome Sciences Centre
Genome Sciences Centre

Dr. Angela Brooks-Wilson is a distinguished scientist at Canada’s Michael Smith Genome Sciences Centre. Her laboratory group investigates the genetic basis of cancer susceptibility. One of her primary interests is lymphoid cancers, which include Hodgkin lymphoma, non-Hodgkin lymphoma, chronic lymphocytic leukemia and myeloma. Through collaboration with members of the Cancer Control Research Group at BC Cancer including Dr. John Spinelli, Dr. Brooks-Wilson studies the interaction between genetic susceptibility and environmental triggers in causing lymphoid cancers.

Learn More

Dr. Gregg Morin, PhD

Head of Proteomics, Canada’s Michael Smith Genome Sciences Centre, BC Cancer
Genome Sciences Centre

Dr. Gregg Morin received his PhD in Biochemistry from the University of Colorado, Boulder in 1988. Following a postdoctoral fellowship in the Department of Molecular Biophysics and Biochemistry at Yale University and an assistant professorship at the University of California, Davis, Dr. Morin was the Director of the Department of Molecular Biology and Biochemistry at Geron Corporation. In 2004, he joined Canada’s Michael Smith Genome Sciences Centre where he is currently the Head of Proteomics.

Learn More

Dr. Aly Karsan, MD

Distinguished Scientist, Canada's Michael Smith Genome Sciences Centre, BC Cancer
Genome Sciences Centre

After receiving his MD from Queen’s University in Kingston, Ontario and a rotating internship at Lion’s Gate Hospital, North Vancouver, BC, Dr. Karsan practiced medicine in rural BC and the Northwest Territories before working as a volunteer with Médecins Sans Frontières. He then completed his residency in Hematological Pathology at the University of British Columbia (UBC) followed by a Research Fellowship at the University of Washington.

Learn More

Dr. Martin Hirst, PhD

Head of Epigenomics, Canada’s Michael Smith Genome Sciences Centre, BC Cancer
Genome Sciences Centre

Dr. Hirst is a Senior Scientist and Head of Epigenomics at Canada’s Michael Smith Genome Sciences Centre at BC Cancer, Associate Professor in the Department of Microbiology and Immunology and Associate Director of the Michael Smith Laboratory at the University of British Columbia (UBC).

Learn More

Dr. Sharon Gorski, PhD

Distinguished Scientist, Canada’s Michael Smith Genome Sciences Centre, BC Cancer
Genome Sciences Centre

Dr. Gorski completed a PhD in Biology and Biomedical Sciences at Washington University School of Medicine, St. Louis, MO in 1999. She then conducted postdoctoral studies at the BC Cancer where she utilized genomics approaches to study cell death and cell survival pathways. Dr. Gorski is currently a Distinguished Scientist at Canada’s Michael Smith Genome Sciences Centre at BC Cancer and a Professor in the Department of Molecular Biology and Biochemistry at Simon Fraser University.

Learn More

Dr. Marianne Sadar, PhD

Distinguished Scientist, Canada’s Michael Smith Genome Sciences Centre, BC Cancer
Genome Sciences Centre

Dr. Sadar has served in leadership roles internationally and was the first Canadian to serve as Chair of the USA Army’s Department of Defence’s Programmatic Panel for Prostate Cancer Research. She was President of the Society of Basic Urologic Research (USA) and a board member of education, research, and scientific advisory committees and boards for American and Canadian non-profit societies. Of note, Dr. Sadar was appointed to the Board of Trustees for Canada’s National Museum of Science and Technology by the Minister of Heritage.

Learn More

Dr. Isabella Tai, MD/PhD, FRCP(C)

Senior Scientist, Canada’s Michael Smith Genome Sciences Centre, BC Cancer
Genome Sciences Centre

Dr. Isabella Tai received her PhD, MD and FRCP(C) designations in Internal Medicine and Gastroenterology from the University of Toronto. She began her academic career as a postdoctoral research fellow in the Department of Cancer Biology at Harvard Medical School. In 2003, she took a faculty position in the Department of Medicine at the University of British Columbia where she is now Associate Professor of Gastroenterology, and became a Senior Scientist at Canada’s Michael Smith Genome Sciences Centre and a Staff Physician at Vancouver Hospital and Health Services.

Learn More

Dr. Stuart Peacock, PhD

Distinguished Scientist; Department Head; Co-Director of ARCC
Cancer Control Research

Dr. Stuart Peacock holds the Leslie Diamond Chair in Cancer Survivorship in the Faculty of Health Sciences at Simon Fraser University. He is Co-Director of the Canadian Centre for Applied Research in Cancer Control (ARCC) and Head of Cancer Control Research at BC Cancer. He is also a member of the Board of Directors of the Canadian Agency for Drugs and Technologies in Health, and past President of the International Society on Priorities in Health Care. He has held university positions in Canada, Australia and the UK.

Dr. Ryan Morin, PhD

Senior Scientist, Canada’s Michael Smith Genome Sciences Centre
Genome Sciences Centre

Dr. Ryan Morin has been studying the genetic nature of lymphoid cancers using genomic methods for more than a decade. During his doctoral training at the University of British Columbia and BC Cancer, he pioneered the use of transcriptome and whole genome sequencing to identify driver mutations in non-Hodgkin lymphomas. Over the course of his training, he published a series of papers describing some of the most common genetic features of diffuse large B-cell (DLBCL) and follicular lymphomas including EZH2, KMT2D, CREBBP and MEF2B.

Learn More

Dr. Ryan Brinkman, PhD

Distinguished Scientist
Terry Fox Laboratory

Ryan Brinkman’s research is focused on developing and applying flow cytometry bioinformatics approaches to advance our understanding of human health and disease.  His early work centered on creating data standards and a free, open source computational infrastructure to support high throughput computational statistical analysis of flow cytometry data.

Learn More

Dr. Florian Kuchenbauer, MD, PhD

Senior Scientist
Terry Fox Laboratory

Dr. Florian Kuchenbauer received his M.D. education at the Ludwig-Maximilians-University in Munich, Germany in 2001 and completed an M.D. thesis at the Max-Planck-Institute for Psychiatry in 2002. He then started residency training at the Department of Hematology/Oncology, Klinikum Grosshadern, Munich, Germany (2001-2004) before obtaining a PhD degree at the Terry Fox Laboratory, BC Cancer and Department of Experimental Medicine, University of British Columbia under the supervision of Dr. Keith Humphries (2005-2009).

Learn More

Dr Andrew Weng, MD, PhD

Distinguished Scientist
Terry Fox Laboratory

Dr. Andrew Weng attended Stanford University for his undergraduate studies in Biological Sciences and then obtained his MD and PhD degrees at the University of Chicago/Pritzker School of Medicine. He did his clinical residency training in Anatomic Pathology with a fellowship in hematopathology, followed by four years of postdoctoral research training at Brigham & Women’s Hospital in Boston.

Learn More

Dr. Arman Rahmim, PhD, DABSNM

Senior Scientist
Integrative Oncology

Dr. Rahmim is Associate Professor of Radiology and Physics at the University of British Columbia (UBC) as well as Senior Scientist and Provincial Medical Imaging Physicist at BC Cancer. He received his MSc in condensed matter physics and PhD in medical imaging physics at UBC. Following doctoral studies, he was recruited by Johns Hopkins University (JHU) to lead the high resolution brain PET imaging physics program and to pursue research at the JHU Department of Radiology.

Learn More

Dr. Rachel Murphy, PhD

Scientist
Cancer Control Research

Dr. Rachel Murphy, is an Scientist at the BC Cancer, and Assistant Professor in the Centre of Excellence in Cancer Prevention, School of Population and Public Health, University of British Columbia. She is also an Associate Member in the Human Nutrition Program at the Faculty of Land and Food Systems. Dr. Murphy holds a PhD in Nutrition and Metabolism from the University of Alberta. Her research program aims to advance the understanding of relationships between diet, nutrition and chronic disease, particularly cancer.

Selected Affiliated Academic Departments

UBC Interdisciplinary Oncology Program (IOP)

The UBC Interdisciplinary Oncology program (IOP) is a graduate program designed to appeal to a broad range of students interested in cancer research. IOP offers advanced study and research in a variety of fields relating to oncology.

Learn More

UBC Medical Genetics

The UBC Department of Medical Genetics is an inspiring and productive community of scholars of genetics and genomics. Faculty members in the Department of Medical Genetics are at the forefront of their fields using cutting edge genetic, epigenetic, genomic, and bioinformatic methodologies to gain insight into diseases such as cancer.

Learn More

UBC Pathology and Laboratory Medicine

The UBC Department of Pathology and Laboratory Medicine offers the opportunity to study with numerous world-renowned faculty and research programs, many of which work at BC Cancer. The Department of Pathology will consider and train students with varied backgrounds in science and medicine.

Learn More

UBC Bioinformatics

The UBC Bioinformatics program integrates academic centres in computer science, statistics, molecular biology and biotechnology, with translational groups at hospitals and at the clinical interface. This innovative partnership between the University of British Columbia, Simon Fraser University and BC Cancer allows students to interact with experts in the field of bioinformatics, and opportunities to complete work on real bioinformatics problems.

Learn More

UBC Experimental Medicine

The Experimental Medicine Program is intended for trainees seeking a career in research, offering opportunities and facilities for advanced studies in experimental medicine, leading toward the M.Sc. and Ph.D. degrees. Faculty members of the Experimental Medicine program conduct research in a wide range of basic and clinically relevant areas.

Learn More

UBC Reproductive and Developmental Sciences

The UBC Reproductive and Developmental Sciences Program (RDS program) is the only graduate program in Canada based in a Department of Obstetrics and Gynecology. RDS students have the opportunity to interact with basic science and clinical research faculty, which can lead to the development of research projects addressing important clinical issues for women.

Learn More

UBC Biochemistry and Molecular Biology

The Department of Biochemistry and Molecular Biology offers opportunities for research fundamental to advancing basic science and which may be translated to help tackle human disease. The graduate programs in Biochemistry and Molecular Biology prepare students for careers in academic, industrial or professional positions in British Columbia and beyond.

Learn More

UBC Pharmacology and Therapeutics

Graduate studies in Pharmacology and Therapeutics allow students to gain broad-based exposure to fundamental as well as medically-related aspects of drug research. Faculty members are engaged in research in clinical pharmacology as well as drug development, and students pursuing an advanced degree will have the opportunity to interact with basic as well as clinical scientists.

Learn More

SFU Molecular Biology and Biochemistry

The SFU Department of Molecular Biology and Biochemistry (MBB) is noted for producing a significant number of prominent industry leaders and researchers. The MBB provides flexibility for students to tailor their degree to suit their interests and goals, and now includes the option of an Interdisciplinary Oncology Graduate Specialization in partnership with the BC Cancer to train the next generation of cancer research leaders.

Learn More

Back to top